S&P 500   3,358.17 (+1.81%)
DOW   27,696.38 (+1.92%)
QQQ   276.18 (+1.70%)
AAPL   114.47 (+1.95%)
MSFT   209.49 (+0.80%)
FB   256.62 (+0.71%)
GOOGL   1,461.17 (+1.54%)
AMZN   3,158.26 (+2.04%)
TSLA   418.81 (+2.82%)
NVDA   516.21 (+0.24%)
BABA   276.11 (+1.85%)
CGC   14.29 (+0.85%)
GE   6.24 (+2.13%)
MU   49.13 (-0.02%)
AMD   78.94 (+1.13%)
T   28.62 (+2.07%)
F   6.72 (+3.23%)
ACB   4.89 (-3.17%)
GILD   62.94 (+1.11%)
NFLX   486.86 (+0.82%)
DIS   126.33 (+1.88%)
BAC   24.25 (+3.24%)
BA   165.46 (+6.04%)
S&P 500   3,358.17 (+1.81%)
DOW   27,696.38 (+1.92%)
QQQ   276.18 (+1.70%)
AAPL   114.47 (+1.95%)
MSFT   209.49 (+0.80%)
FB   256.62 (+0.71%)
GOOGL   1,461.17 (+1.54%)
AMZN   3,158.26 (+2.04%)
TSLA   418.81 (+2.82%)
NVDA   516.21 (+0.24%)
BABA   276.11 (+1.85%)
CGC   14.29 (+0.85%)
GE   6.24 (+2.13%)
MU   49.13 (-0.02%)
AMD   78.94 (+1.13%)
T   28.62 (+2.07%)
F   6.72 (+3.23%)
ACB   4.89 (-3.17%)
GILD   62.94 (+1.11%)
NFLX   486.86 (+0.82%)
DIS   126.33 (+1.88%)
BAC   24.25 (+3.24%)
BA   165.46 (+6.04%)
S&P 500   3,358.17 (+1.81%)
DOW   27,696.38 (+1.92%)
QQQ   276.18 (+1.70%)
AAPL   114.47 (+1.95%)
MSFT   209.49 (+0.80%)
FB   256.62 (+0.71%)
GOOGL   1,461.17 (+1.54%)
AMZN   3,158.26 (+2.04%)
TSLA   418.81 (+2.82%)
NVDA   516.21 (+0.24%)
BABA   276.11 (+1.85%)
CGC   14.29 (+0.85%)
GE   6.24 (+2.13%)
MU   49.13 (-0.02%)
AMD   78.94 (+1.13%)
T   28.62 (+2.07%)
F   6.72 (+3.23%)
ACB   4.89 (-3.17%)
GILD   62.94 (+1.11%)
NFLX   486.86 (+0.82%)
DIS   126.33 (+1.88%)
BAC   24.25 (+3.24%)
BA   165.46 (+6.04%)
S&P 500   3,358.17 (+1.81%)
DOW   27,696.38 (+1.92%)
QQQ   276.18 (+1.70%)
AAPL   114.47 (+1.95%)
MSFT   209.49 (+0.80%)
FB   256.62 (+0.71%)
GOOGL   1,461.17 (+1.54%)
AMZN   3,158.26 (+2.04%)
TSLA   418.81 (+2.82%)
NVDA   516.21 (+0.24%)
BABA   276.11 (+1.85%)
CGC   14.29 (+0.85%)
GE   6.24 (+2.13%)
MU   49.13 (-0.02%)
AMD   78.94 (+1.13%)
T   28.62 (+2.07%)
F   6.72 (+3.23%)
ACB   4.89 (-3.17%)
GILD   62.94 (+1.11%)
NFLX   486.86 (+0.82%)
DIS   126.33 (+1.88%)
BAC   24.25 (+3.24%)
BA   165.46 (+6.04%)
Log in
OTCMKTS:SCRC

ScripsAmerica Stock Forecast, Price & News

$440.00
-35.00 (-7.37 %)
(As of 09/24/2020 12:00 AM ET)
Add
Compare
Today's Range
$440.00
Now: $440.00
$440.00
50-Day Range
$0.00
MA: $476.40
$525.00
52-Week Range
$0.00
Now: $440.00
$0.06
Volume1,417 shs
Average Volume239,991 shs
Market Capitalization$62.08 billion
P/E RatioN/A
Dividend YieldN/A
BetaN/A
There is no company description available for ScripsAmerica Inc.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 2.3Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.46 out of 5 stars


Industry, Sector and Symbol

Industry --
Sub-IndustryN/A
Sector--
Current SymbolOTCMKTS:SCRC
CUSIPN/A
CIKN/A
PhoneN/A

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

EmployeesN/A
Market Cap$62.08 billion
Next Earnings DateN/A
OptionableNot Optionable
$440.00
-35.00 (-7.37 %)
(As of 09/24/2020 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive SCRC News and Ratings via Email

Sign-up to receive the latest news and ratings for SCRC and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











ScripsAmerica (OTCMKTS:SCRC) Frequently Asked Questions

How has ScripsAmerica's stock price been impacted by Coronavirus (COVID-19)?

ScripsAmerica's stock was trading at $570.00 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, SCRC stock has decreased by 22.8% and is now trading at $440.00.
View which stocks have been most impacted by COVID-19
.

Who are some of ScripsAmerica's key competitors?

What other stocks do shareholders of ScripsAmerica own?

Based on aggregate information from My MarketBeat watchlists, some companies that other ScripsAmerica investors own include Progenics Pharmaceuticals (PGNX), Chiasma (CHMA), Whiting Petroleum (WLL), Volkswagen (VOW3) and Antares Pharma (ATRS).

Who are ScripsAmerica's key executives?

ScripsAmerica's management team includes the following people:
  • Brian Ettinger, Chairman of the Board, Chief Executive Officer (Age 61)
  • Adam Brosius, President, Director (Age 50)
  • Jeffrey J. Andrews, Chief Financial Officer (Age 62)
  • Pelligrino L. Certa, Director (Age 49)
  • Joseph Camardo M.D., Independent Director (Age 61)
  • Michael Imperiale M.D., Independent Director (Age 53)
  • William Austin Lewis IV, Independent Director (Age 40)
  • Andrius Pranskevicius, Independent Director (Age 34)

What is ScripsAmerica's stock symbol?

ScripsAmerica trades on the OTCMKTS under the ticker symbol "SCRC."

How do I buy shares of ScripsAmerica?

Shares of SCRC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is ScripsAmerica's stock price today?

One share of SCRC stock can currently be purchased for approximately $440.00.

How big of a company is ScripsAmerica?

ScripsAmerica has a market capitalization of $62.08 billion.

What is ScripsAmerica's official website?

The official website for ScripsAmerica is scripsamerica.com.

This page was last updated on 9/28/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.